Category: Medication

August 24, 2026

FDA Adds Boxed Warning to Ferric Carboxymaltose Following Petition Led by Cure HHT’s Dr. Scott Olitsky

When something in HHT care isn’t working the way it should, speaking up matters. On August 13, 2026, the US Food and Drug Administration…

The world’s leading patient advocacy organization for hereditary hemorrhagic telangiectasia (HHT). We work to find, treat, and cure it.

Cure HHT on Facebook
Cure HHT on Instagram
Cure HHT on LinkedIn
Cure HHT on YouTube

Sign up for our newsletter

Accreditation and membership

Cure HHT provides information to educate patients, caregivers, and healthcare professionals about HHT. Content on this website is developed with input from qualified medical professionals and is periodically updated to reflect advancements in research and clinical care.

The medical information on this website is for general informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Decisions regarding the care and treatment of HHT or any other medical condition should always be made in consultation with a physician or other qualified healthcare provider.

PO Box 329, Monkton, MD 21111

Privacy Policy

Terms of Use

Category: Medication

FDA Adds Boxed Warning to Ferric Carboxymaltose Following Petition Led by Cure HHT’s Dr. Scott Olitsky